All In Biotech

Free tool

FAERS Monitor: Benicar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021286 or its brand name (Benicar, Olmesartan Medoxomil). Reports on generic versions are filed under their own applications.

Reports

36,093

Serious

23,598

65% of reports

Hospitalization

13,579

Death reported

1,635

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • sprue-like enteropathy3,497
  • diarrhoea2,512
  • weight decreased2,231
  • dizziness2,127
  • gastrooesophageal reflux disease2,079
  • nausea2,059
  • acute kidney injury2,028
  • drug ineffective1,997
  • fatigue1,702
  • headache1,428
  • haemorrhoids1,369
  • dyspnoea1,362
  • hypotension1,330
  • constipation1,315
  • vomiting1,219

Reports by year received

View as table
YearReports
2004486
2005567
2006572
2007777
20081,069
20091,285
20101,815
20111,741
20121,930
20131,205
20141,455
20152,878
20162,914
20173,142
20183,211
20192,113
20201,373
20211,203
20221,537
20231,436
20241,168
20251,210
20261,006

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,018,066 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sprue-like enteropathySignal3,4971417.11333.91,441,206
haemorrhoidsSignal1,36943.941.653,383
gastrooesophageal reflux diseaseSignal2,07915.414.827,405
acute kidney injurySignal2,0287.87.511,969
weight decreasedSignal2,2314.74.56,501
hypotensionSignal1,3303.93.72,852
constipationSignal1,3153.53.32,391
dizzinessSignal2,1272.52.41,935
diarrhoeaSignal2,5122.32.21,839
nausea2,0591.51.5376
vomiting1,2191.51.4215
dyspnoea1,3621.41.3161
headache1,4281.31.3119
fatigue1,7021.31.2104
drug ineffective1,9970.90.833

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.